Academic Bibliography

Show Sort by

Your filters: cql: parent exact "PULMONARY PHARMACOLOGY & THERAPEUTICS"

Mark
- journalArticle
- A1
- open access
Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils

Guy Brusselle (UGent) , Matthew Germinaro, Sivan Weiss and James Zangrilli

(2017) PULMONARY PHARMACOLOGY & THERAPEUTICS. 43. p.39-45
Mark
- misc
Risk of a biased assessment of the evidence when limiting literature searches to the English language : macrolides in asthma as an illustrative example

Guy Brusselle (UGent) and Francesco Blasi

(2015) PULMONARY PHARMACOLOGY & THERAPEUTICS. 31. p.109-110
Mark
- journalArticle
- A1
- open access
The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease

Kai-Michael Beeh, Jan Westerman, Anne-Marie Kirsten, Jacques Hébert, Lars Grönke, Alan Hamilton, Kay Tetzlaff and Eric Derom (UGent)

(2015) PULMONARY PHARMACOLOGY & THERAPEUTICS. 32. p.53-59
Mark
- journalArticle
- A1
- open access
Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases

Lisa Dupont (UGent) , Constantinos Glynos (UGent) , Ken Bracke (UGent) , Peter Brouckaert (UGent) and Guy Brusselle (UGent)

(2014) PULMONARY PHARMACOLOGY & THERAPEUTICS. 29(1). p.1-6
Mark
Investigation of 5-HT4 receptors in bronchial hyperresponsiveness in cigarette smoke-exposed mice

Lisa Dupont (UGent) , Ken Bracke (UGent) , Joris H De Maeyer, Valérie Compan, Guy Joos (UGent) , Romain Lefebvre (UGent) and Guy Brusselle (UGent)

(2014) PULMONARY PHARMACOLOGY & THERAPEUTICS. 28(1). p.60-67
Mark
Exposing a deadly alliance: novel insights into the biological links between COPD and lung cancer

Karim Vermaelen (UGent) and Guy Brusselle (UGent)

(2013) PULMONARY PHARMACOLOGY & THERAPEUTICS. 26(5). p.544-554
Mark
Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases

Juanita HJ Vernooy, Niki DJ Ubags, Guy Brusselle (UGent) , Jan Tavernier (UGent) , Benjamin T Suratt, Guy Joos (UGent) , Emiel FM Wouters and Ken Bracke (UGent)

(2013) PULMONARY PHARMACOLOGY & THERAPEUTICS. 26(4). p.464-472
Mark
Statins, systemic inflammation and risk of death in COPD: the Rotterdam Study

Lies Lahousse (UGent) , Daan W Loth, Guy Joos (UGent) , Albert Hofman, Hubert GM Leufkens, Guy Brusselle (UGent) and Bruno H Stricker

(2013) PULMONARY PHARMACOLOGY & THERAPEUTICS. 26(2). p.212-217
Mark
Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD

KMC Verhamme, ASM Afonso, C van Noord, MD Haag, PJ Koudstaal, Guy Brusselle (UGent) and MCJM Sturkenboom

(2012) PULMONARY PHARMACOLOGY & THERAPEUTICS. 25(1). p.19-26
Mark
- journalArticle
- A1
Bronchodilating effect of combined therapy with ipratropium bromide and ondasetron in patients with COPD

Romain Pauwels, Guy Joos (UGent) , Charles Fogarty, Isidore Faiferman, Sandra Hirschberg, Rupert Vessey and Emiel Wouters

(2008) PULMONARY PHARMACOLOGY & THERAPEUTICS. 21(2). p.385-392

Academic Bibliography

Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils

Risk of a biased assessment of the evidence when limiting literature searches to the English language : macrolides in asthma as an illustrative example

The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease

Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases

Investigation of 5-HT4 receptors in bronchial hyperresponsiveness in cigarette smoke-exposed mice

Exposing a deadly alliance: novel insights into the biological links between COPD and lung cancer

Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases

Statins, systemic inflammation and risk of death in COPD: the Rotterdam Study

Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD

Bronchodilating effect of combined therapy with ipratropium bromide and ondasetron in patients with COPD

Contents

Support

Contact